Difference between revisions of "Part:BBa K3561024"
| Line 5: | Line 5: | ||
This peptide is expected to be a palladium reducing peptide. This peptide is modified by our team from the palladium reducing peptide SVTQNKY(Chiu et al., 2010). We have incorporated a tryptophan residue into the peptide as it was reported that tryptophan is capable of reducing palladium (Chiu et al., 2010). We implemented a double tryptophan structure at residues 2 and 3 as it was said that a double tryptophan is more effective than a single tryptophan structure in gold(Tan et al., 2010). We would like to investigate whether a double tryptophan will be more effective in palladium. We also want to investigate what effects will there have if we inserted the tryptophan residue at different positions. | This peptide is expected to be a palladium reducing peptide. This peptide is modified by our team from the palladium reducing peptide SVTQNKY(Chiu et al., 2010). We have incorporated a tryptophan residue into the peptide as it was reported that tryptophan is capable of reducing palladium (Chiu et al., 2010). We implemented a double tryptophan structure at residues 2 and 3 as it was said that a double tryptophan is more effective than a single tryptophan structure in gold(Tan et al., 2010). We would like to investigate whether a double tryptophan will be more effective in palladium. We also want to investigate what effects will there have if we inserted the tryptophan residue at different positions. | ||
| − | This peptide has an isoelectric point of 9.7, a molecular weight of | + | This peptide has an isoelectric point of 9.7, a molecular weight of 1.0 kDa and hydrophobicity of 24.12. The serine residue at position 1 is reported to be important in binding with palladium(Chiu et al., 2010). The tryptophan residue at positions 2 and 3 are reported to reduce palladium(Chiu et al., 2010). The amino acid sequence of the peptide is SWWQNKY. |
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
Revision as of 13:57, 11 October 2020
W2W3SVTQNKY
This peptide is expected to be a palladium reducing peptide. This peptide is modified by our team from the palladium reducing peptide SVTQNKY(Chiu et al., 2010). We have incorporated a tryptophan residue into the peptide as it was reported that tryptophan is capable of reducing palladium (Chiu et al., 2010). We implemented a double tryptophan structure at residues 2 and 3 as it was said that a double tryptophan is more effective than a single tryptophan structure in gold(Tan et al., 2010). We would like to investigate whether a double tryptophan will be more effective in palladium. We also want to investigate what effects will there have if we inserted the tryptophan residue at different positions.
This peptide has an isoelectric point of 9.7, a molecular weight of 1.0 kDa and hydrophobicity of 24.12. The serine residue at position 1 is reported to be important in binding with palladium(Chiu et al., 2010). The tryptophan residue at positions 2 and 3 are reported to reduce palladium(Chiu et al., 2010). The amino acid sequence of the peptide is SWWQNKY.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]